With the recent rally in the stock price, there is a limited upside and thus the brokerage maintains ‘Reduce’ rating with a target price of Rs 6,149 at 50 times FY27 P/E.
Doctor holding pills. (Source: Yeko Photo Studio for freepik)
NDTV Profit’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer NDTV Profit’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.